Showing results (91-100 of 113) with videos related to

Sort By:
Pageof 12
Neonatology|August 8, 2013
The SafeBoosC phase II randomised clinical trial: a treatment guideline for targeted near-infrared-derived cerebral tissue oxygenation versus standard treatment in extremely preterm infantsAdelina Pellicer, Gorm Greisen, Manon Benders, et al.
The Pediatric Infectious Disease Journal|September 18, 2015
Respiratory Syncytial Virus Preterm (32-36 Completed Weeks of Gestation) Risk Estimation Measure for RSV Hospitalization in Ireland: A Prospective StudyMargaret Sheridan-Pereira, Joan Murphy, Julie Sloan, et al.
Pediatric Research|April 21, 2021
Cerebral oxygen saturation and autoregulation during hypotension in extremely preterm infantsLiesbeth Thewissen, Gunnar Naulaers, Dries Hendrikx, et al.
Trials|December 21, 2019
Detailed statistical analysis plan for the SafeBoosC III trial: a multinational randomised clinical trial assessing treatment guided by cerebral oxygenation monitoring versus treatment as usual in extremely preterm infantsMathias Lühr Hansen, Adelina Pellicer, Christian Gluud, et al.
Trials|June 21, 2013
A phase II randomized clinical trial on cerebral near-infrared spectroscopy plus a treatment guideline versus treatment as usual for extremely preterm infants during the first three days of life (SafeBoosC): study protocol for a randomized controlled trialSimon Hyttel-Sorensen, Topun Austin, Frank van Bel, et al.
BMJ (Clinical Research Ed.)|January 9, 2015
Cerebral near infrared spectroscopy oximetry in extremely preterm infants: phase II randomised clinical trialSimon Hyttel-Sorensen, Adelina Pellicer, Thomas Alderliesten, et al.
Trials|October 29, 2023
The effects of cerebral oximetry in mechanically ventilated newborns: a protocol for the SafeBoosC-IIIv randomised clinical trialMaria Linander Vestager, Mathias Lühr Hansen, Marie Isabel Rasmussen, et al.
Trials|January 1, 2020
Cerebral near-infrared spectroscopy monitoring versus treatment as usual for extremely preterm infants: a protocol for the SafeBoosC randomised clinical phase III trialMathias Lühr Hansen, Adelina Pellicer, Christian Gluud, et al.
Trials|October 7, 2023
Cerebral oximetry monitoring versus usual care for extremely preterm infants: a study protocol for the 2-year follow-up of the SafeBoosC-III randomised clinical trialMarie Isabel Rasmussen, Mathias Lühr Hansen, Adelina Pellicer, et al.
Trials|January 6, 2026
Cerebral oximetry monitoring versus usual care for extremely preterm infants: a detailed statistical analysis plan for the 2-year follow-up of the participants of the SafeBoosC-III randomised clinical trialMarie Isabel S Rasmussen, Mathias Lühr Hansen, Adelina Pellicer, et al.
Pageof 12